Atara Biotherapeutics Announces Third Quarter 2021 Financial Results and Operational Progress

Go back to Atara Biotherapeutics Announces Third Quarter 2021 Financial Results and Operational Progress

ATARA Biotherapeutics (ATRA) Tops Q3 EPS by 4c

November 4, 2021 7:39 AM EDT

ATARA Biotherapeutics (NASDAQ: ATRA) reported Q3 EPS of ($0.90), $0.04 better than the analyst estimate of ($0.94). Revenue for the quarter came in at $5.4 million versus the consensus estimate of $3.92 million.

For earnings history and earnings-related data on ATARA Biotherapeutics (ATRA) click here.

... More